Preventing Nearsightedness in Children: What Science Says About Slowing Myopia Progression

Table of Contents

• Key Points
• Understanding Myopia: Why This Research Matters
• How This Review Was Conducted
• What Causes Myopia?
• Genetic Factors
• Biological Mechanisms Behind Myopia
• The Role of Outdoor Activities
• The Role of Near Work (Reading and Close-Up Tasks)
• Treatment Options: What the Clinical Trials Show
• Biofeedback Visual Training
• Spectacles and Contact Lenses
• Clinical Implications: What This Means for Patients
• Limitations of This Review
• Recommendations for Parents and Patients
• Frequently Asked Questions
• Source Information

Key Points

• By 2050, half the world's population may be myopic; high myopia can lead to severe eye complications.
• Outdoor time prevents myopia onset but does not reliably slow progression once myopia exists.
• Low-dose atropine (0.01%) is the most effective safe treatment for slowing myopia in children.
• Progressive lenses and bifocal contacts help only modestly; certain children may benefit more.
• Ortho-K slows eye growth but carries a risk of corneal infection, so it's not first-line.

Understanding Myopia: Why This Research Matters

Myopia, commonly called "nearsightedness," is one of the most widespread vision disorders in the world. In children, it is primarily caused by excessive elongation of the eyeball — meaning the eye grows too long from front to back, causing distant objects to appear blurry.

The problem is growing at an alarming rate. According to a 2018 report published in Nature, myopia has become an epidemic in the developed countries of East and Southeast Asia, where up to 80–90% of children attending secondary school (ages 17–18) are affected.

Western countries are not far behind. The European Eye Epidemiology Consortium analyzed population-based cross-sectional studies and found that myopia prevalence in Europe is also rising dramatically. Notably, the numbers vary significantly by age group: 46% of 25-year-olds are myopic, compared to only 15% of 75-year-olds. This striking difference suggests that younger generations — who have grown up with more indoor activities, screens, and intensive schooling — are developing myopia at much higher rates than their grandparents did.

In a landmark meta-analysis, Holden and colleagues estimated the worldwide growth of myopia and high myopia (defined as a loss of 6.00 diopters or more). Their projections are sobering:

• Myopia: expected to rise from 1,406 million people (22.9% of the world population) in 2000 to 4,758 million (49%) in 2050
• High myopia: expected to rise from 163 million (2.7%) in 2000 to 938 million (9.8%) in 2050

In other words, by 2050, half of the world's population may be nearsighted. This represents a significant social and economic burden on global healthcare systems.

Not every country shows this trend, however. In a Danish cross-sectional study, Jacobsen and colleagues reported a significant decrease in high myopia from 1882 onward, with a declining tendency from 1964 to 2004. Among 4,681 Danish male conscripts, the prevalence of myopia (defined as spherical equivalent ≤ −0.5 D) was 12.8%, and high myopia (spherical equivalent < −6.5 D) was only 0.3%. Similarly, French and colleagues compared European Caucasian children aged 6–7 and 12–13 years living in Sydney, Australia, and in Northern Ireland, finding a relatively low prevalence of myopia — 5% and 15%, respectively.

The danger of myopia goes beyond needing glasses. High myopia is associated with serious, sight-threatening complications. The Rotterdam Eye Study, a population-based cohort study, found that among highly myopic eyes with bilateral visual impairment, 39% of patients had myopic maculopathy (damage to the central retina), 17% had open-angle glaucoma, and 5% had cataracts. Additionally, research shows that an earlier onset of myopia in childhood is associated with a more severe degree of the disease by adulthood. This is why finding effective ways to slow myopia progression in children is so critical.

How This Review Was Conducted

The authors of this review performed a systematic computerized search of the scientific literature from the earliest available records through December 2017. They searched the electronic databases PubMed, MEDLINE, and the Cochrane Collaborations for all English-language articles dealing with myopia control therapies.

The search used the following keywords and MeSH terms: "Myopia" alone or in combination with "control," "progression," "pediatrics," "prevention," "atropine," "orthokeratology," "contact lenses," "spectacles," "outdoor activities," "near work," "epidemiology," "genetics," "pathogenesis," and "dopamine."

Each relevant article was thoroughly assessed, and the reference lists of those articles were checked to identify any additional studies that could be included. The reviewers were not blinded to the names of the investigators or the sources of publication. Study eligibility was first judged on titles and abstracts; then full manuscripts were obtained and reviewed before a final inclusion decision was made.

What Causes Myopia?

Myopia is a multifactorial disease — meaning it does not have a single cause. Instead, it develops from a complex interaction between genetic factors (including parental myopia and ethnicity) and environmental factors (such as time spent outdoors and near work habits).

Genetic Factors

Research has clearly demonstrated a positive association between parental myopia and a child's risk of developing the condition. Ip and colleagues showed that both parental myopia and ethnicity significantly influence a child's refractive error (spherical equivalent refraction) and eyeball length (axial length) in a study of 12-year-old Australian children.

Myopia inheritance is complex. While common myopia is generally transmitted as a "complex trait" (involving multiple genes and environmental factors), high myopia can be inherited either as a complex trait or as a classic Mendelian trait, including:

• Autosomal dominant (AD) inheritance — one copy of the altered gene is enough to cause the condition
• Autosomal recessive (AR) inheritance — both copies of the gene must be altered
• X-linked recessive (XL) inheritance — the gene is on the X chromosome

Through linkage analysis, researchers have identified 18 myopia and high myopia genetic loci (specific locations on chromosomes), including MYP2, MYP3, and MYP5. These discoveries open the door to screening possible candidate genes responsible for the disease.

Twin studies have provided powerful evidence for the heritability of myopia. The Twin Eye Study demonstrated that the heritability of myopia in monozygotic (identical) twins was 90% (95% CI, 81–95%). More recently, the Guangzhou Twin Eye Study identified the important role of peripheral refraction (how the eye focuses light from the sides) in myopia progression, suggesting a significant genetic contribution with a heritability of 55–84%.

Experimental myopia studies have helped characterize specific genes involved in the disease's development. These genes share common features: they can regulate ocular (eye) growth, they can be modified in induced-myopia animal models, and they are widely expressed in the sclera (the white outer coat of the eye), choroid (the blood vessel layer beneath the retina), and retina. Among them, the TGF-beta/BMPs signaling pathways appear to play a particularly important role. Animal models have shown that reduced expression of TGF-beta isoforms in the sclera is associated with decreased collagen synthesis — and therefore a greater predisposition to abnormal axial elongation of the eye.

However, genome-wide association studies (GWAS) have shown that the susceptible gene loci causing refractive error play only a marginal role in the overall risk of developing myopia — accounting for just 0.5–2.9% of the risk. This suggests that non-genomic factors, such as epigenetic changes and the environment, are much more influential. In a prospective cohort study of 5,257 participants, Verhoeven and colleagues compared subjects with the same degree of genetic risk and found that environmental factors — particularly higher levels of education — were more significantly associated with the onset of myopia than lower levels of education. In short, myopia should be viewed as a complex mosaic in which the interaction between genes and environment is crucial.

Biological Mechanisms Behind Myopia

Our understanding of how the eye grows and becomes myopic dates back to 1977, when Wiesel and Raviola accidentally discovered in animal models that visual form deprivation (blocking clear vision) causes myopic axial elongation. This finding led to the theory that the retina can locally control eye growth.

Since then, numerous animal models have shown that the eye adjusts its axial growth in response to imposed defocus (blur). In non-human primate models, researchers demonstrated that manipulating peripheral retinal defocus with bifocal contact lenses can change eye growth and refractive status. Specifically, axial myopia can be produced by imposing a peripheral hyperopic defocus (where light from the periphery focuses behind the retina). In a study on marmosets, Benavente-Perez and colleagues suggested that imposing a positive defocus on the retina could be an effective strategy for slowing myopia progression. Strikingly, these responses could be triggered locally in the eye — if visual deprivation was directed only to certain retinal areas, only those areas' corresponding eye growth was affected.

This means the retina detects the sign of defocus and signals the eye to grow. Even more surprising is the role of the choroid (the vascular layer between the retina and sclera): it can change its thickness to move the retina closer to the focal plane, a kind of biological autofocus mechanism.

In humans, however, imposing defocus produces smaller changes in axial length than in animal experiments. The COMET and STAMP clinical trials observed that children treated with progressive addition lenses (PALs) showed only small refractive changes relative to the amount of defocus imposed. The researchers hypothesized that the more gradual accommodation (the eye's focusing mechanism) induced by progressive lenses in children reduces peripheral retinal defocus — and therefore reduces the stimulus for eye growth. More studies are still needed to clarify the role of accommodation in suppressing the retinal error signal and slowing eye growth in children.

Many biochemical pathways have been investigated as potential drivers of myopia. While cholinergic, nitric oxide (NO), and insulin pathways have all been studied, the importance of dopamine (DA) remains central. In 1990, Stone and colleagues first demonstrated reduced dopamine levels in the eyes of chicks with visual deprivation. Subsequent studies confirmed that chicks treated with negative lenses had decreased levels of DOPAC (3,4-Dihydroxyphenylacetic acid, dopamine's primary metabolite) in the vitreous humor (the gel-filled cavity of the eye). These findings suggest an inverse relationship between dopamine levels and myopic eye growth — less dopamine, more growth.

Dopamine works through two families of receptors:

• D1-like receptors (D1 and D5) — located on bipolar, apocrine, and ganglion cells in the retina
• D2-like receptors (D2, D3, D4) — located on retinal pigment epithelium (RPE) cells and neuroepithelial cells

Traditional thinking held that D2-like receptors played the main role in myopia development, but recent findings support a combined action of both D1-like and D2-like receptors.

The retinal pigment epithelium (RPE) has also attracted significant attention. The RPE releases growth factors that regulate scleral remodeling in response to experimental form deprivation myopia (FDM) and flickering light-induced myopia (FLM). Intriguingly, a study by Luo and colleagues revealed paradoxically increased levels of dopamine in the RPE of guinea pigs with FLM. This suggests that different retinal pathways may cause FDM and FLM, but the RPE could represent the final common pathway in myopic scleral remodeling.

Other molecules have been investigated as well. The administration of 7-methylxanthine (7-mx) in young rabbits reinforced the posterior sclera by increasing its collagen fibril content. In guinea pigs, 7-mx slowed the amount of eye elongation induced by form deprivation and prevented thinning of the posterior sclera. These animal results have prompted interest in methylxanthines as potential treatments for myopia prevention.

Melatonin, a hormone that regulates sleep-wake cycles, has also been implicated. Systemic administration of melatonin in chicks is associated with choroidal thinning. A human study found that myopic subjects have higher serum levels of melatonin combined with lower serum dopamine compared with non-myopic subjects. This finding reinforces the importance of light exposure and circadian rhythm in myopia development, since both are strongly connected to melatonin metabolism.

Light exposure, in particular, is known to protect against deprivation myopia. Animal studies in chicks and monkeys have shown that daily exposure to bright light (15,000–30,000 lux — comparable to a sunny day outdoors) can limit the onset of experimental myopia. In chicks, a proportional effect has been demonstrated: brighter light results in less refractive error. Light exposure likely works by modulating the release of dopamine and other biomolecules. The exact relationship between dopamine, sunlight, and outdoor time still requires further study — this is one of the most active areas of current myopia research.

The Role of Outdoor Activities

One of the most exciting findings in myopia research is the protective effect of time spent outdoors. Multiple epidemiological studies have confirmed this connection.

The Guangzhou randomized trial followed 952 children aged 6–7 over a 3-year period, giving them an additional daily outdoor activity session, and compared them to 951 control children of the same age with their usual pattern of outdoor activities. The results showed that the intervention group had less myopic shift (measured as spherical equivalent refraction): a mean of −1.42 D vs. −1.59 D in the control group, a difference of 0.17 D (95% CI, 0.01 D to 0.33 D; p = 0.04). This translates to a 23% relative reduction in the incidence of myopia in the intervention group.

These results were echoed in a prospective interventional study by Wu and colleagues in Taiwan. They introduced a "recess outside the classroom" (ROC) program for 571 children and found that more outdoor activities reduced the onset of myopia by 8.4% in the ROC group compared with the control group after 1 year (8.41% vs. 17.65%; p < 0.001).

The "Anyang Childhood Eye Study" examined 2,276 Chinese children aged 10–15 and found a significant association between outdoor activities and a slower rate of axial elongation — but only in children who were not myopic at the start of the study (high versus low activity tertile: −0.036 mm/year; p = 0.009). Children who were already myopic at baseline did not show a significant effect of outdoor time on reducing axial elongation (high versus low tertile: −0.005 mm/year; p = 0.595).

The "Handan Offspring Myopia Study" also reported a significant inverse relationship between outdoor activities and the incidence of myopia in rural children in China, though the effect size was small (odds ratio [OR], 95% CI: 0.82, 0.70–0.96).

A key conclusion from these studies is that outdoor activities are more effective at preventing the onset of myopia than at slowing its progression. A meta-analysis by Xiong and colleagues confirmed this. It found that more time outdoors had a protective effect for both the incidence of myopia (clinical trials: risk ratio [RR] = 0.536, 95% CI = 0.338 to 0.850; longitudinal cohort studies: RR = 0.574, 95% CI = 0.395 to 0.834) and the prevalence of the disease (cross-sectional studies: OR = 0.964, 95% CI = 0.945 to 0.982). However, in a dose-response analysis, no significant association was found between more outdoor activities and myopia progression (R² = 0.00064).

Even the neighborhood a child lives in seems to matter. A cross-sectional study of schoolchildren in Indonesia found that the prevalence of uncorrected refractive error was 10.1%, 12.3%, 3.8%, and 1% among children in urban, suburban, exurban, and rural areas, respectively. The higher prevalence in urban and suburban areas may be explained by a lack of outdoor activities combined with more intensive near work due to higher educational demands. Adding to this, a study by Read and colleagues found that daily light exposure played a more important role in myopia development in Australian children than the amount of physical activity itself — so it's specifically the bright light, not just moving around, that matters.

Why does outdoor time protect against myopia? Animal research points again to dopamine. Ashby and colleagues exposed chicks to high luminance levels but injected them with spiperone (500 µM), a D2-dopaminergic antagonist. The drug blocked the protective effect of bright light — meaning dopamine signaling is required for light to slow myopia development.

The Role of Near Work (Reading and Close-Up Tasks)

Near work — reading, writing, using screens, and other close-up activities — has been extensively studied as an independent risk factor for myopia. However, unlike outdoor activities, the evidence is less consistent, and a definitive link has yet to be firmly established.

A Singapore myopia study found that teenagers who spent more than 20.5 hours per week reading and writing were significantly more likely to develop myopia (odds ratio 1.12, 95% CI 1.04–1.20, p = 0.003).

The Sydney Myopia Study, which analyzed 12-year-old Australian children, looked at two specific aspects of near work:

• Close reading distance (< 30 cm): associated with a 2.5 times higher probability of developing myopia (p = 0.02)
• Continuous reading (> 30 minutes): associated with a 1.5 times higher probability of developing myopia (p = 0.0003)

However, the overall time spent on near work activities was not significant in multivariate analyses for myopia (defined as SER ≤ −0.50 D).

A 3-year follow-up cohort study — the Beijing Myopia Progression Study — found a positive association between myopia and near work only in the group of students who already had a greater near work load at baseline (hazard ratio, 95% CI: 5.19, 1.49–18.13). By contrast, other studies have found no significant correlation. For example, Rose and colleagues found no relevant changes in myopia prevalence in 6-year-old children, even across low (0–2 h), moderate (1.6–3.1 h), and high (> 3.0 h) daily amounts of near work.

The most comprehensive evidence comes from a systematic review and meta-analysis by Huang and colleagues, which included 12 cohort studies and 15 cross-sectional studies on the association between myopia and near work in children. Their results showed that:

• More near work was associated with higher odds of myopia (odds ratio [OR] = 1.14; 95% CI = 1.08–1.20)
• The odds of myopia increased by 2% for every additional diopter-hour of weekly near work (OR: 1.02; 95% CI = 1.01–1.03)

More broadly, several studies have demonstrated a strong positive association between higher levels of education and the prevalence of myopia. This could be explained by multiple factors: both an increase in near work activity and a simultaneous reduction in outdoor activities among more highly educated individuals.

Taken together, this evidence confirms the multifactorial nature of myopia: near work is an important independent risk factor, but it does not act alone.

Treatment Options: What the Clinical Trials Show

Several randomized clinical trials have investigated the effectiveness of various treatments for slowing myopia progression. The key trials are summarized below with their specific findings.

Soft Contact Lenses (SCLs)

• Aller TA (2016): A 1-year randomized study of 186 American children (ages 8–18) with baseline SER of −2.69 ± 1.40 D. The treated group (wearing multifocal soft contact lenses) progressed only −0.22 ± 0.34 D, compared with −0.79 ± 0.43 D in the control group.
• Lam CS (2014): A 2-year randomized, double-blind study of 221 Hong Kong children (ages 8–13) with myopia from −1.00 to −5.00 D. The control group progressed 0.40 D/year with 0.18 mm/year axial elongation, while the treated group progressed only 0.30 D/year with 0.13 mm/year axial elongation.

Orthokeratology (Ortho-K)

• Cho P (2005): A 2-year pilot study of 35 Hong Kong children (ages 7–12) found a gain of 2.09 ± 1.34 D for the treated group.
• Cho P (2012): A 2-year randomized, single-masked study of 102 Hong Kong children (ages 6–10) with myopia from 0.50 to 4.00 D. The control group showed 0.63 ± 0.26 mm of axial elongation, while the treated group showed only 0.36 ± 0.24 mm.

Despite these promising results, orthokeratology should not be considered a first-line strategy because of the high risk of infectious keratitis (corneal infection) and the relatively low compliance among patients.

Pirenzepine (an Anti-Muscarinic Agent)

• Tan DT (2005): A 1-year randomized, placebo-controlled, double-masked study of 353 Singaporean children (ages 6–12) with myopia from −0.75 to 4.00 D. The placebo/pirenzepine group progressed 0.70 D, the pirenzepine/pirenzepine group progressed 0.47 D, while the control group progressed 0.84 D.
• Siatkowski RM (2008): A 2-year randomized, placebo-controlled, double-masked study of 174 American children (ages 8–12) with myopia from −0.75 to −4.00 D (astigmatism ≤ 1.00 D) found a 0.41 D gain for the treated group relative to placebo.

Atropine (the Most Effective Option)

• Chua WH (2006, ATOM1 study): A 2-year randomized, placebo-controlled, double-masked study of 400 Asian children (ages 6–12) with myopia from 1.00 to −6.00 D. The control group progressed −1.20 ± 0.69 D with 0.38 ± 0.38 mm of axial elongation, while the atropine 1% group progressed only 0.28 ± 0.92 D with −0.02 ± 0.35 mm — essentially no progression at all.

Atropine works by blocking muscarinic receptors in the eye, though its exact mechanism for slowing myopia is still not fully understood. High-dose atropine (1%) is very effective but causes significant side effects, including light sensitivity (photophobia) and blurry near vision, because it paralyzes the eye's focusing muscles and dilates the pupil.

The key breakthrough has been low-dose atropine (0.01%). According to this review, low-dose atropine has been proven to be an effective and safe treatment over the long term, with the lowest rebound effect (meaning myopia is less likely to rapidly worsen when the drops are stopped) and negligible side effects. At present, atropine ophthalmic drops appear to be the most effective treatment for slowing myopia progression.

Progressive Addition Lenses (PALs) and Bifocal Spectacles

• The COMET Group (2001): A 3-year randomized study of 469 American children (average age 9) with myopia between −1.25 and −4.50 D. Children treated with progressive addition lenses showed a gain of only 0.2 D compared with those wearing standard single-vision lenses. While the result was statistically significant, the clinical effect was small.

Biofeedback Visual Training

Biofeedback visual training is based on a theory dating back to the 1920s, when Bates proposed that overwork of the extra-ocular muscles (the muscles that move the eye) could cause changes in accommodation (focusing). The idea is that training can modify the autonomic nervous system's control over the focusing process.

However, the scientific evidence does not support this approach. Rupolo and colleagues evaluated visual training using an acoustic biofeedback technique in a non-randomized prospective study of 33 female students. After 12 months, no significant differences were found between the treated and control groups. Earlier non-randomized clinical studies reported similar findings of no efficacy.

More recently, a case-control study evaluated the effectiveness of Chinese eye exercises in controlling myopia in 261 children (mean age 12.7 ± 0.5 years). Over a 2-year follow-up period, the study found no significant association between eye exercises and the risk of developing myopia (OR = 0.73, 95% CI: 0.24–2.21), nor with myopia progression (OR = 0.79, 95% CI: 0.41–1.53).

Conclusion: There is no consistent evidence that biofeedback visual training is effective in slowing myopia progression.

Spectacles and Contact Lenses: Limited but Real Effects

In everyday clinical practice, single-vision spectacle lenses (SVSLs) and standard contact lenses are commonly prescribed to children to correct myopia. However, these do not slow the underlying progression of the disease. Progressive addition lenses (PALs) and bifocal spectacles are occasionally prescribed specifically for the purpose of slowing myopia down.

The reasoning behind PALs treatment is that reducing accommodative lag (the tendency of the eye to focus "behind" the target during near work) reduces retinal hyperopic blur. However, the mechanism is not fully understood and the clinical results have been modest.

A 3-year Finnish randomized controlled trial enrolling 240 schoolchildren aged 9–11 reported that myopia progression was more closely associated with the amount of near work, and that diminishing accommodative effort with bifocal or reading spectacles was ineffective.

The Correction of Myopia Evaluation Trial (COMET) enrolled 469 children aged 9 and randomly assigned them to either PALs with a +2.00 addition or regular single-vision spectacles. After 3 years of follow-up, the progression of myopia (measured by autorefraction after cycloplegia — using dilating drops to relax the eye's focus) showed a statistically significant but clinically small gain of only 0.2 D and 0.11 mm in the PALs group.

Subgroup analysis by Gwiazda and colleagues revealed a more interesting picture. Children with larger accommodative lags (more than 0.43 D for a 33 cm target) combined with near esophoria (a tendency of the eyes to turn inward during near work) benefited substantially more: the difference in progression between PALs and single-vision lenses was −1.08 D − (−1.72 D) = 0.64 ± 0.21 D.

Building on this, the COMET2 Study — a double-masked, multicenter randomized trial — specifically selected myopic children who had near esophoria and at least 1.00 D of accommodative lag (defined as an accommodative response of less than 2.50 D for a 3.00-D demand). Over a 3-year follow-up, they found a gain in spherical equivalent refraction of 0.28 D for the treated group.

Clinical Implications: What This Means for Patients

For parents wondering how to protect their children's vision, the research offers both encouraging and cautionary messages. The most important takeaways are:

• Outdoor time prevents onset, but not progression. Getting children outside for at least 1–2 hours of bright daylight each day appears to significantly reduce the risk of developing myopia in the first place. However, once myopia has developed, additional outdoor time does not reliably slow its progression.
• Atropine eye drops are the most effective treatment for slowing progression. In particular, low-dose atropine (0.01%) balances effectiveness with safety and minimizes the rebound effect that can occur when treatment is stopped. It also avoids the significant side effects (light sensitivity, blurry near vision) of higher-dose atropine.
• Special spectacles and contact lenses offer modest benefits. Progressive addition lenses and bifocal contact lenses can slow myopia somewhat, but the average effect sizes are small. Certain subgroups of children — such as those with large accommodative lag and near esophoria — may benefit more, which is why an individualized approach is important.
• Ortho-K should be approached with caution. While orthokeratology contact lenses can slow axial elongation, the risk of infectious keratitis (a serious corneal infection) and the demands of wearing and caring for rigid contact lenses overnight make it a less attractive first-line option.
• Watch the near work balance. Very high amounts of near work (particularly more than 20 hours per week) are associated with increased myopia risk. Encouraging reading distance above 30 cm and taking breaks from continuous reading (more than 30 minutes at a stretch) are sensible precautions.

Limitations of This Review

Readers should keep several limitations in mind when interpreting these findings. First, the reviewers were not blinded to the names of the investigators or the sources of publication, which could introduce selection bias. Second, the review includes studies with heterogeneous designs, patient populations, and follow-up durations, making direct comparisons difficult.

Many of the clinical trials have relatively short follow-up periods (1–3 years), so the long-term effectiveness and safety of these interventions — especially over the full course of childhood eye development — remains uncertain. The rebound effect after stopping treatment, particularly with higher doses of atropine, is an important concern that requires careful management. Additionally, the exact biological mechanisms by which atropine and other treatments slow eye growth remain incompletely understood, which limits our ability to design even better therapies.

It should also be noted that the environmental evidence — particularly for near work — is not entirely consistent across studies. While the overall pattern points toward a real association, other confounding factors (such as education level and time spent outdoors) may play a role. Finally, much of our understanding of myopia mechanisms comes from animal models (chicks, guinea pigs, monkeys), which may not perfectly replicate the human condition.

Recommendations for Parents and Patients

Based on this systematic review of the available scientific evidence, here are practical steps that parents and patients can consider:

1. Encourage daily outdoor time. Aim for at least 1–2 hours of outdoor activity in bright daylight each day, especially for children who have not yet developed myopia. This is one of the most effective, low-cost preventive measures.
2. Monitor near work habits. Encourage a reading distance of at least 30 cm and take breaks every 30 minutes of continuous reading or screen time. Consider limiting total

   Frequently Asked Questions

   What is myopia and why is it becoming more common in children?

   Myopia, or nearsightedness, happens when the eyeball grows too long, making distant objects blurry. It is increasing worldwide, and researchers project that by 2050, about half of the global population may be nearsighted. In some East Asian countries, up to 80–90% of older teens are affected.

   Can spending more time outdoors prevent myopia in children?

   Yes, several studies show that outdoor time can help prevent myopia from starting. In one randomized trial, children who had extra outdoor sessions had a 23% lower incidence of myopia. However, for children who already have myopia, outdoor time does not reliably slow its progression.

   What is the most effective treatment for slowing myopia progression in children?

   According to this scientific review, low-dose atropine eye drops (0.01%) appear to be the most effective and safest long-term treatment for slowing myopia progression in children. They have minimal side effects and a low rebound effect when treatment is stopped, unlike higher-dose atropine.

   Are special eyeglasses or contact lenses effective for slowing myopia?

   Progressive addition lenses and bifocal contact lenses offer modest benefits. In a large trial, progressive lenses slowed progression by only 0.2 diopters over 3 years. However, certain children, such as those with large accommodative lag and near esophoria, may benefit more from these lenses.

   What is orthokeratology and is it a good first-line treatment?

   Orthokeratology, or Ortho-K, uses rigid contact lenses worn overnight to reshape the cornea and slow eye elongation. In one study, treated children had significantly less axial growth than controls. However, it is not recommended as a first-line option because of the risk of serious corneal infection and lower patient compliance.

   Does near work like reading or screen time cause myopia?

   Near work is a risk factor, but the evidence is mixed. A meta-analysis found that more near work is associated with higher odds of myopia, and the odds increase by 2% for each additional diopter-hour per week. Very high amounts (over 20 hours weekly) were linked to greater risk in one study.

   What practical steps can parents take to protect their child's vision?

   The review recommends at least 1–2 hours of bright outdoor daylight daily, especially for children without myopia. Keep reading distance at least 30 cm and take breaks every 30 minutes of continuous near work. These are low-cost preventive measures based on current evidence.